Zappy Zapolin, Lamar Odom, Roland Rick Perry

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Above: Lamar Odom and Psychedelic Spokesman Mike Zappy Zapolin We're Calling a Sector Bottom, and Psycheceutical (BWVI) as Our Favorite. We launched the Psychedelic Stock Review...

Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.

Adding to 2023 Biotech Stock Review Watch List. We Think This One Has Legs. Starting Due Diligence Now. It takes us about 15 minutes after talking...

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects FT. LAUDERDALE, FL /...

Ardelyx (ARDX) Resubmits New Drug Application to FDA.

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
ARDX, Roland Rick Perry

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

LIVE QUOTE Ardelyx Enters the Danger Zone* With Tenapanor. The company produced favorable (albeit very technical) information (data) at the National Kidney Foundation 2023 Spring Clinical...

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced...

And We Have a $26.4 Billion Winning Trifecta!

THREE PREVIOUS WINNERS* Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired by Gilead Sciences (GILD) Dicerna (DRNA) $3.30 to $38.25 up...

Sanofi (SNY) to Acquire Provention Bio (PRVB) for $25 a Share. Gains 243%.

Up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of hard partying at the C-3. How pray tell,...
Internet Stock Review, Biotech Stock Review, Roland Rick Perry

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.

Stormin..Live Quote We're still not sure how to pronounce it...but Wall Street likes it. News Archive Unicycive Therapeutics (UNCY) $2.73. We're now up 249%. Unicycive (UNCY) Shoots and...
Unicycive

Unicycive (UNCY) Shoots and Scores, up 40% Today!

We're up 126% Since December, and That Ain't Bad. Note: This isn't the end, it's just the beginning. LIVE QUOTE Adding Unicycive (UNCY) $0.75 to...

Latest article

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Thursday afternoon, the 30th, while we were nearing completion of an updated...

Paving Past Obstacles on the Path to US Biosecurity

GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China. National biosecurity has become a frequent topic of conversation in...

Dinner Presentation With BioStem Technologies, Inc. (BSEM) in Boca Raton, FL

LIVE QUOTE LONGER TERM CHART Contact Ray Oliver at Bear Creek Capital for details. RECENT NEWS PRESENTATION https://youtu.be/Au-pIqDHyto?si=_JKFAhwT-vvLSFqe WOUND CARE REPORT Global Wound Care Market to Reach USD 30.48 Billion by...